3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
3
Warts
2
Keratosis, Actinic
2
Hyperthermia
2
Hematologic Neoplasms
2
Hemangioma
2
Squamous Intraepithelial Lesions
1
Skin Neoplasms
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Pituitary Neoplasms
1
Pelvic Neoplasms
1
Pain
1
Obesity
1
Nonmelanoma Skin Cancers
1
Mucositis
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Melanoma
1
Kidney Neoplasms
1
Invasive Fungal Infections
1
Insulinoma
1
Infertility, Female
1
Infertility
1
Inappropriate Prescribing
1
Hyperinsulinism
1
Hemorrhage
1
Head and Neck Carcinoma
1
Interventions
radium Ra 223 dichloride
1
niraparib
1
enzalutamide
1
darolutamide
1
capivasertib
1
cabazitaxel
1
apalutamide
1
abiraterone
1
Solutions
1
Prednisone
1
Injections
1
Docetaxel
1
Carboplatin
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Metastatic Castration-resistant Prostate Cancer (mCRPC)
×
Solutions
×
Clear all
NCT03903835
2025-04-09
ProBio
Karolinska Institutet
Phase 3
Recruiting
750 enrolled